Which biomarkers can help predict adverse outcomes in COVID-

Which biomarkers can help predict adverse outcomes in COVID-19?
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of coronavirus disease 2019 (COVID-19), was declared a pandemic on March 11, 2020, by the World Health Organisation (WHO).
The severity of this infectious disease has strained healthcare resources to capacity in many parts of the world. Many healthcare systems have seen an inadequate number of intensive care unit (ICU) beds as well as mechanical ventilators available to treat the influx of patients the pandemic has wrought. The critically low supply of these vital resources underscores the need for clinicians to identify biomarkers that can predict factors such as ICU stay and mortality. This would help to allocate these lifesaving resources appropriately.

Related Keywords

Wuhan , Hubei , China , United States , Jinyintan , Qinghai , India , Marzia Khan , Marzia Khanmay , Tongji Hospital Of Huazhong University Science , Journal Of Clinical Medicine Research , World Health Organisation , Coronavirus Disease , Image Credit , Corona Borealis Studio , Clinical Medicine , Tongji Hospital , Huazhong University , Jinyintan Hospital , Wuhan Pulmonary Hospitals , Biomarker , Coronavirus Disease Covid 19 , Ars Cov 2 , Coronavirus , D Dimer , Healthcare , Hospital , Intensive Care , Laboratory , Liver , Ortality , Pandemic , Platelet , Espiratory , Cars , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Troponin , Virus , சீனா , ஒன்றுபட்டது மாநிலங்களில் , கிங்காய் , இந்தியா , இதழ் ஆஃப் மருத்துவ மருந்து ஆராய்ச்சி , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , படம் கடன் , கொரோனா போரியாலிஸ் ஸ்டுடியோ , மருத்துவ மருந்து , பயோமார்க் , ஐவர் , அரசு ,